The discovery of GlyMCA has overcome the issue of easy metabolism by bacterial bile salt hydrolase, which affects endogenous intestinal FXR antagonists, and has shown great potency in improving obesity and insulin resistance caused by lipid accumulation [5]. Here, NR1H4 is linked to obesity disorder.